SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: art slott who wrote (2930)2/16/1999 10:37:00 AM
From: Bruce Rozenblit  Respond to of 3725
 
Last time some ACC articles were published, someone out there was able to post a link to the articles so we could read them. I'd sure like to know what dollar amounts Rumberger came up with and how Schmermund structured his algorithm. This is highly significant information. Where are you great linker of knowledge?



To: art slott who wrote (2930)2/16/1999 10:53:00 AM
From: art slott  Read Replies (1) | Respond to of 3725
 
>minimized direct costs and maximized cost-effectiveness in population groups with low to moderate disease prevalence." <

Above the age of 40 thats probably most of us.

The tide is on our side. The simple fact is its painless, cost effective, and a very good predictor of CAD risk.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News